Wu et al. demonstrated that linc00635-001 silencing accompanied by gefitinib treatment sensitized lung cancer cells HCC827-8-1 to gefitinib-induced cytotoxicity through the suppression of Akt activation [21]. Here, AKT1 is linked to lung carcinoma.